Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...
Recent testing from Consumer Reports and the FDA has found elevated levels of lead in cinnamon products and spice mixes. You ...
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).
Hence, this was an area where many ingredient and process suppliers at IFT First focused. “It is important for the flavor in ...
Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.
The plaintiff, Skylar Williams, accused Galderma Laboratories of producing a skin-care line that contains benzene. In one of ...
Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Herbals LLC has issued a nationwide recall of all lots of Vail-Bon Jie Yang Wan supplement capsules due to the presence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback